The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Epimed International sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Epimed International Inc (Epimed) is a medical device company that offers surgical and medical instruments. The company designs, develops, manufactures, and distributes pain management devices, radiofrequency, cryo and regional anesthesia products. Its pain management products comprise trays and kits, epidural introducer needles, standard needles, specialty needles, accessories and radiation safety. Epimed’s radiofrequency products include probes, RF cannulas and grounding pads. The company provides regional anesthesia products such as catheters and needles, trays, kits and accessories, simulation products, and support products. It operates its manufacturing plant in Johnstown, New York. Epimed is headquartered in Dallas, Texas, the US. Key subsidiaries of Epimed International include Epimed Pain Management.
The key metrics of Epimed International related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Epimed International is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Epimed International.
For a detailed understanding of the performance of Epimed International, buy the report here.